Targeting ALOX12: design, synthesis, and anti-inflammatory mechanism study of linker-free PROTAC molecules
Bioorganic Chemistry · 2026-09 · 180 · 110206
DOI: 10.1016/j.bioorg.2026.110206 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-09. Verfasst von Xiaolan Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou 215001, PR China. Hauptthemen laut MEDLINE: Drug Design, Arachidonate 12-Lipoxygenase, Anti-Inflammatory Agents, Non-Steroidal, Pancreatitis. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Suzhou Municipal Science and Technology Bureau.
Abstract (Originalsprache)
Acute pancreatitis (AP) is a life-threatening disorder with no specific anti-inflammatory treatments available. 12-lipoxygenase (ALOX12) acts as a key regulator of inflammation and pyroptosis during AP progression. In this study, we established an LPS-induced inflammatory model in AR42J cells and confirmed that ALOX12 strongly aggravates AP-associated inflammation and pyroptosis. The ALOX12-targeted compound MH-04 was identified via virtual screening, with an IC₅₀ value of 0.72 μM. We further synthesized eight novel PROTAC molecules using linker-free PROTAC technology. Among these candidates, MH-06 was found to specifically target and effectively degrade ALOX12 protein. Mechanistic assays revealed that MH-06 dose-dependently decreases reactive oxygen species (ROS) production, restores mitochondrial function, inhibits the MAPK signaling pathway and modulates macrophage polarization, thereby lowering the release of pro-inflammatory cytokines. In the cerulein-induced AP mouse model, MH-06 exerted remarkable therapeutic and preventive effects. Collectively, this work offers new perspectives and promising chemical entities for the development of targeted therapies against AP. Given its favorable pharmacological profiles, MH-06 merits further detailed investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou 215001, PR China.
- Department of Gastroenterology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou 215001, PR China.. Electronic address: zhklu@njmu.edu.cn.
Förderung
- Suzhou Municipal Science and Technology Bureau
Zitieren
APA
Li, X., Shen, S., Duan, C., Hua, T., Xu, Y., Wang, L., & Lu, Z. (2026). Targeting ALOX12: design, synthesis, and anti-inflammatory mechanism study of linker-free PROTAC molecules. Bioorganic Chemistry, 180, 110206. https://doi.org/10.1016/j.bioorg.2026.110206
Vancouver
Li X, Shen S, Duan C, Hua T, Xu Y, Wang L, et al. Targeting ALOX12: design, synthesis, and anti-inflammatory mechanism study of linker-free PROTAC molecules. Bioorganic Chemistry. 2026;180:110206. doi:10.1016/j.bioorg.2026.110206
BibTeX
@article{Li2026,
author = {Li, Xiaolan and Shen, Sitian and Duan, Chaoqin and Hua, Tingyan and Xu, Ya and Wang, Lin and Lu, Zhongkai},
title = {Targeting ALOX12: design, synthesis, and anti-inflammatory mechanism study of linker-free PROTAC molecules},
journal = {Bioorganic Chemistry},
year = {2026},
volume = {180},
pages = {110206},
doi = {10.1016/j.bioorg.2026.110206}
}
EUVIMED